Please login to the form below

VISFO appoints new Senior Advisor

Healthtech company VISFO announces new partnership to support continued business growth in 2022

VISFO – a leader in the healthtech industry – is delighted to welcome Chris Grimes-Crompton as senior advisor to VISFO’s executive team. Chris will play a crucial role in supporting the company’s expansion within US and European markets, leveraging VISFO’s period of rapid growth.

With over 25+ years’ experience within the life sciences industry, Chris will be drawing upon his experience and network to accelerate VISFO’s product development and client offering. Chris has been responsible for leading some of the industry’s highest profile product launches, working with diverse cross functional teams and product categories.

Chris will support VISFO in developing the company’s unique software platforms and services to ensure they meet the needs of their clients; supporting them to digitally transform their business and enhance customer engagement.

Chris says: ‘The life sciences industry can benefit enormously from fully embracing digital technology; allowing businesses to move faster, be more accurate and enhance their productivity.

‘More data isn’t the solution. The industry needs a strategic partner that can help them navigate through the world of data; not just give them more. I’m particularly impressed by the approach that VISFO takes by fusing together subject matter expertise, scientific knowledge and technical capability that allows them to solve problems and deliver solutions for their clients.’

The strategic insights that come from thinking differently when it comes to data makes VISFO’s ability to solve problems and create software platforms incredibly agile. VISFO focuses on supporting cross functional teams prior to and during the early stages of launch, working across clinical operations, market access, medical and commercial during periods when speed and accuracy matter most.

Dr Max Noble, VISFO’s founder and CEO, adds: ‘Chris has decades of experience, launched some of the biggest drugs in the world and never settles for second best. This will be incredibly valuable for VISFO and complement the experience we already have within the business. At VISFO we’re all about people, attracting only the best thinkers who will enhance our cognitive diversity and allow us to continue diverging from the status quo to deliver excellence and solve the most important problems in the industry’.

4th April 2022



Company Details


0800 1337834

Contact Website

The Old Floor Mill
Mill Royd Street
West Yorkshire

Latest content on this profile

VISFO appoints new Senior Advisor
Healthtech company VISFO announces new partnership to support continued business growth in 2022
VISFO kicks off Enigma scholarships at University of York
VISFO – a global leader in the healthtech industry – has successfully launched its scholarship programme at the University of York to give students from a widening participation background greater access to higher education and an opportunity to embark on a ground-breaking project that will see the students come together to create a ‘social good’.
VISFO invests in a new brand as it continues to grow its client base in the US and Europe
VISFO – a healthtech consultancy based in West Yorkshire – is taking the pharmaceutical (pharma) industry by storm revealing a new brand direction for 2022.
VISFO launch new ‘Enigma Scholarships’ at the University of York to support students from disadvantaged backgrounds
VISFO – a West Yorkshire-based healthcare consultancy – has announced big plans to support the next generation of students, launching a new scholarship programme with the University of York to help students from disadvantaged backgrounds realise their academic and entrepreneurial potential.
VISFO sees exponential growth as demand from pharma clients soars
VISFO, the West Yorkshire-based healthcare consultancy – has seen demand for its heathcare consulting services and software platforms soar over the past year as global pharmaceutical (pharma) clients look for more agile solutions to answer the unmet needs of patients.